Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sigyn Therapeutics Inc (SIGY)

Sigyn Therapeutics Inc (SIGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,204
  • Shares Outstanding, K 1,605
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,340 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta -0.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.19
  • Most Recent Earnings $-0.36 on 11/14/25
  • Next Earnings Date 04/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2523 +197.23%
on 01/09/26
1.2500 -40.01%
on 01/14/26
-0.9600 (-56.14%)
since 12/16/25
3-Month
0.2523 +197.23%
on 01/09/26
2.0000 -62.51%
on 12/01/25
-1.2501 (-62.51%)
since 10/30/25
52-Week
0.2523 +197.23%
on 01/09/26
5.0000 -85.00%
on 09/10/25
-2.4501 (-76.57%)
since 01/16/25

Most Recent Stories

More News
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Presentation on Tuesday, October 21st at 4:00 PM PTSan Diego, California--(Newsfile Corp. - October 21, 2025) - Sigyn Therapeutics, Inc. (OTCQB: SIGY), a developer of dialysis-like therapies to address...

SIGY : 0.7499 (+21.95%)
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Presentation on Tuesday, October 21st at 4:00 PM PTSan Diego, California--(Newsfile Corp. - October 17, 2025) - Sigyn Therapeutics, Inc. (OTCQB: SIGY), a developer of dialysis-like therapies to address...

SIGY : 0.7499 (+21.95%)
The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access

Cardiovascular disease remains the world's leading cause of death, claiming more than 17.9 million lives annually according to the World Health Organization . Despite decades of medical advances, existing...

RMTI : 1.0600 (+6.00%)
FMS : 24.08 (-1.11%)
PFE : 27.22 (+2.76%)
DVA : 140.83 (-5.62%)
SIGY : 0.7499 (+21.95%)
Sigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange

SAN DIEGO, CA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage medical technology...

OTC.VN : 0.530 (-5.36%)
SIGY : 0.7499 (+21.95%)
Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board

SAN DIEGO, CA, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused...

SIGY : 0.7499 (+21.95%)
Sigyn Therapeutics™ Appoints H. David Humes, MD to Its Scientific Advisory Board

SAN DIEGO, CA, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused...

SIGY : 0.7499 (+21.95%)

Business Summary

Sigyn Therapeutics Inc. is a medical technology company. It is focused on the treatment of life-threatening inflammatory conditions. Sigyn Therapeutics Inc., formerly knonw as Reign Resources Corporation, is headquartered in San Diego, California USA.

See More

Key Turning Points

3rd Resistance Point 0.7499
2nd Resistance Point 0.7499
1st Resistance Point 0.7499
Last Price 0.7499
1st Support Level 0.7499
2nd Support Level 0.7499
3rd Support Level 0.7499

See More

52-Week High 5.0000
Fibonacci 61.8% 3.1864
Fibonacci 50% 2.6261
Fibonacci 38.2% 2.0659
Last Price 0.7499
52-Week Low 0.2523

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar